You are here: Industry Insights > lung cancer

News List

Artificial lung cancer tissue could help find new drug treatments worldpharmanews
March 06, 2019
A 3D hydrogel created by researchers in U of T Engineering Professor Molly Shoichet's lab is helping University of Ottawa researchers to quickly screen hundreds of potential drugs for their ability to fight highly invasive cancers.
Intuitive Surgical receives FDA clearance for its lung cancer biopsy robot fiercebiotech
February 22, 2019
Robotic surgery giant Intuitive Surgical has received an FDA clearance for its minimally invasive lung cancer biopsy system, which features a thin, articulating catheter designed to snake its way through the airway to the periphery of the organ.....
NICE backs Takeda’s Alunbrig in second-line lung cancer pharmaphorum
February 18, 2019
NICE has published final draft guidance recommending regular NHS funding in England for Takeda’s Alunbrig (brigatinib), for ALK-positive advanced non-small cell lung cancer, in patients already treated with Pfizer’s Xalkori.
Auris Health raises another $220M to commercialize its robotic surgery platform fiercebiotech
January 03, 2019
Robotic surgery platform developer Auris Health has raked in another $220 million in equity financing, bringing its fundraising total to more than $700 million.....
InventisBio and Betta Pharma to Co-Develop Novel Drug for Non-Small Cell Lung Cancer pharmafocusasia
January 02, 2019
InventisBio (Shanghai) announced today that it has signed a "Collaboration Agreement" with Betta Pharma (hereinafter referred to as "Betta Pharma").....
Elevated Risk for Lung CA in Lung Transplant Recipients Explored drugs
December 28, 2018
Recipients of a lung transplant, especially a single lung transplant, have an elevated risk for lung cancer, particularly in the native lung, according to a study published online Dec. 18 in the American Journal of Transplantation......
Janssen alums' Aro Biotherapeutics takes aim at centyrins with $13M round fiercebiotech
December 27, 2018
A pair of former Janssen R&D leaders founded Aro Biotherapeutics early this year to develop centyrins—small proteins that could potentially work like antibodies without the accompanying challenges.....
FDA extends review of Merck & Co’s Keytruda in lung cancer use pharmaphorum
December 24, 2018
US regulators have pushed back the deadline for their review of Merck & Co’s immunotherapy Keytruda in certain patients with untreated lung cancer, after the pharmaceutical company submitted new data.
Boehringer employees go door-to-door delivering holiday hope to lung cancer patients fiercepharma
December 19, 2018
'Tis the season for good deeds, and Boehringer Ingelheim employees are doing their part. BI is once again partnering with the Bonnie J. Addario Lung Cancer Foundation (ALCF) to bring holiday cheer directly to lung cancer patients.
Keytruda approved for combination lung cancer therapy pharmaphorum
December 18, 2018
The US Food and Drug Administration (FDA) has approved Merck & Co’s Keytruda plus chemotherapy as a first-line treatment for non-small cell lung cancer (NSCLC).....

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page